source
- Seven new tumor cases reported among patients on Novartis' Zolgensma gene therapyNine patients who have received Novartis' spinal muscular atrophy gene therapy Zolgensma have developed tumors following their treatment, the company confirmed Thursday. Seven of those cases were d…Endpoints · 4d ago↗ source
- Novo Nordisk lifts 2026 profit outlook after Wegovy obesity pill beats forecastsNovo Nordisk announced on Wednesday that it is raising its full-year profit and sales guidance after the third-quarter results for its Wegovy obesity pill came in above analysts' expectations. The…